Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1989-8-9
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0887-2570
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
8
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
191-3
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading |
pubmed-meshheading:2661767-Antibodies, Monoclonal,
pubmed-meshheading:2661767-Antilymphocyte Serum,
pubmed-meshheading:2661767-Graft Rejection,
pubmed-meshheading:2661767-Heart Transplantation,
pubmed-meshheading:2661767-Humans,
pubmed-meshheading:2661767-Immunosuppression,
pubmed-meshheading:2661767-Immunosuppressive Agents,
pubmed-meshheading:2661767-T-Lymphocytes,
pubmed-meshheading:2661767-Time Factors
|
| pubmed:articleTitle |
Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
|
| pubmed:publicationType |
Editorial,
Review
|